Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease

Citation
Am. Garber et Na. Solomon, Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease, ANN INT MED, 130(9), 1999, pp. 719
Citations number
50
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
ANNALS OF INTERNAL MEDICINE
ISSN journal
00034819 → ACNP
Volume
130
Issue
9
Year of publication
1999
Database
ISI
SICI code
0003-4819(19990504)130:9<719:COATSF>2.0.ZU;2-T
Abstract
Background: The appropriate roles for several diagnostic tests for coronary disease are uncertain. Objective: To evaluate the cost-effectiveness of alternative approaches to diagnosis of coronary disease. Design: Meta-analysis of the accuracy of alternative diagnostic tests plus decision analysis to assess the health outcomes and costs of alternative di agnostic strategies for patients at intermediate pretest risk for coronary disease. Data Sources: Studies of test accuracy that met inclusion criteria; publish ed information on treatment effectiveness and disease prevalence. Target Population: Men and women 45, 55, and 65 years of age with a 25% to 75% pretest risk for coronary disease. Time Horizon: 30 years. Perspective: Societal. Interventions: Diagnostic strategies were initial angiography and initial t esting with one of five noninvasive tests-exercise treadmill testing, plana r thallium imaging, single-photon emission computed tomography (SPECT), str ess echocardiography, and positron emission tomography (PET)-followed by co ronary angiography if noninvasive test results were positive. Testing was f ollowed by observation, medical treatment, or revascularization. Outcome Measures: Life-years, quality-adjusted life-years (QALYs), costs, a nd costs per QALY. Results of Base-Case Analysis: Life expectancy varied little with the initi al diagnostic test; for a 55-year-old man, the best-performing test increas ed life expectancy by 7 more days than the worst-performing test. More sens itive tests increased QALYs more. Echocardiography improved health outcomes and reduced costs relative to stress testing and planar thallium imaging. The incremental cost-effectiveness ratio was $75 000/QALY for SPECT relativ e to echocardiography and was greater than $640 000 for PET relative to SPE CT. Compared with SPECT, immediate angiography had an incremental cost-effe ctiveness ratio of $94 000/QALY. Results of Sensitivity Analysis: Qualitative findings varied little with ag e, sex, pretest probability of disease, or the test indeterminacy rate. Res ults varied most with sensitivity to severe coronary disease. Conclusions: Echocardiography, SPECT, and immediate angiography are cost-ef fective alternatives to PET and other diagnostic approaches. Test selection should reflect local variation in test accuracy.